Expanding into the U.S. offers Indian pharmaceutical companies massive growth opportunities—but without proper U.S. tax planning, profits silently drain away. High compliance costs, inefficient entity structures, and overlooked tax obligations can significantly reduce margins. Strategic tax planning enables Indian pharma firms to optimize operations, improve cash flow, and compete eff... https://indamadvisors.com/how-lack-of-us-tax-planning-reduces-profit-margins-for-indian-pharmaceutical/